BWAYNasdaqSurgical & Medical Instruments & ApparatusAlso trades as BRSYF
Brainsway Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 20, 2026
$11.99+0.55 (+4.81%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 66.6
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 12, 2026 | Before market open | $17.10M | $0.07 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 11, 2026 | Before market open | $14.50M | $0.07 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 13, 2025 | Before market open | $12.60M | $0.05 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 11, 2025 | Before market open | $11.40M | $0.04 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 6, 2024 | Before market open | $10.00M | $0.02 | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 6, 2024 | Before market open | $9.00M | $0.00 | – |
| Q4 FY2022 Ended Dec 31, 2022 | Mar 15, 2023 | Before market open | – | – | – |
| Q4 FY2021 Ended Dec 31, 2021 | Mar 9, 2022 | Before market open | – | – | – |
Company guidance
Outlook given with results on Aug 12, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | full-year ended December 31, 2026 | $13.00M to $14.00M | Raised |
| Operating incomeGAAP | full-year ended December 31, 2026 | 13.5% to 14% | New |
| RevenueGAAP | full-year ended December 31, 2026 | $68.00M to $70.00M | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Brainsway filed with the SEC
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
OPERATING AND FINANCIAL REVIEW AND PROSPECTS
EX-99.2 to Form 6-K
BrainsWay Reports Second Quarter 2026 Financial Results and Operational
EX-99.1 to Form 6-K
BrainsWay Announces Strategic Investment in Radial Health, Inc.
EX-99.1 to Form 6-K
BrainsWay Announces Minority-Stake Investment in Sound Minds Behavioral
EX-99.1 to Form 6-K
BrainsWay Announces Minority-Stake Investment in Hopemark Health
EX-99.1 to Form 6-K
BrainsWay Reports First Quarter 2026 Financial Results and Operational
EX-99.1 to Form 6-K
BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results
EX-99.1 to Form 6-K
BrainsWay Announces Change in ADS-to-Ordinary Share Ratio
EX-99.1 to Form 6-K
BrainsWay Announces First Coverage Policy for Accelerated Deep TMS
EX-99.1 to Form 6-K
BrainsWay Reports Third Quarter 2025 Financial Results and Operational
EX-99.1 to Form 6-K
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
EX-99.1 to Form 6-K